Advertisement

Effect of Inactivated Corynebacterium on Different Experimental Tumors in Mice

  • M. Roumiantzeff
  • M. Musetescu
  • G. Ayme
  • M. C. Mynard

Abstract

The immunostimulant activities of inactivated Corynebacterium parvum suspension are well described in the work of Halpern et al. (1963). We investigated this nonspecific immunostimulation by measuring the effect of C. parvum on RES-organs stimulation, humoral-adjuvant activity, carbon-clearance stimulation, interferon induction, and protection versus bacterial and viral challenges. All these tests are quantitative and accurate enough to check experimental production precisely, judge different parameters, and control the batches used for animal or clinical trials.

Keywords

Survival Time Protective Activity Tumor System Control Challenge Mean Survival Time 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Amiel, J. L., Litwin, J., and Bérardet, M. (1969). Essais d’immunothérapie active non spécifique par Corynebacterium parvum formolé. Rev. Fr. Etud. Clin. Biol. 14: 909.PubMedGoogle Scholar
  2. Biozzi, G., Stiffel, C., Mouton, D., Bouthillier, Y., and Decreusefond, C. (1972). Importance de l’immunité spécifique et non spécifique dans la défense antitumorale. Ann. Inst. Pasteur, Paris 122: 685.Google Scholar
  3. Chirigos, M. A., Pearson, J., Woods, W., and Spahn, G. (1973). Immunotherapy and chemotherapy in murine leukemia. Virus Tumorogenesis and Immunogenesis. p. 335, ( W. S. Ceglowski and H. Friedman, eds.), New York, Academic Press.Google Scholar
  4. Currie, G. A. and Bagshawe, K. D. (1970). Active immunotherapy with Corynebacterium parvum and chemotherapy in murine fibrosarcomas. Br. Med. J. 1: 541.PubMedCrossRefGoogle Scholar
  5. Fisher, J. C., Grace, W. R., and Mannick, J. A. (1970). The effect of nonspecific immune stimulation with Corynebacterium parvum on patterns of tumor growth. Cancer 26: 1379.PubMedCrossRefGoogle Scholar
  6. Geran, R. I., Greenberg, N. H., MacDonald, M. M., Schumacher, A. M., and Abbott, B. J. (1972). Protocols for screening chemical agents and natural products against animal tumors and other biological systems (third edition). Cancer Chemother. Rep. 3.Google Scholar
  7. Halpern, B. (1973). Inhibition of malignant tumor growth by Corynebacterium parvum and its mechanism. I.R.C.S. Intern. Res. Commun. System (April 1973 ).Google Scholar
  8. Halpern, B. N., Prévot, A. R., Biozzi, G., Stiffel, C., Mouton, D., Morard, J. C., Bouthillier, Y., and Decreusefond, C. (1963). Stimulation de l’activité phagocytaire du système réticuloendothélial provoquée par Corynebacterium parvum. J. Reticuloendothel. Soc. 1: 77.Google Scholar
  9. Halpern, B. N., Biozzi, G., Stiffel, C., and Mouton, D. (1966). Inhibition of tumor growth by administration of killed Corynebacterium parvum. Nature (tond.) 212: 853.Google Scholar
  10. Halpern, B., Fray, A., Crépin, Y., Platica, O., Lorinet, A. M., Rabourdin, A., Sparros, L., and Isac, R. (1973a). Corynebacterium parvum, a potent immunostimulant in experimental infections and in malignancies. Immunopotentiation, p. 217 ( Ciba Foundation, New Series), Elsevier-Excerpta Medica, North-Holland, Amsterdam.Google Scholar
  11. Halpern, B., Fray, A., Crepin, Y., Platica, O., Sparros, L., Lorinet, A. M., and Rabourdin, A. (1973b) Action inhibitrice du Corynebacterium parvum sur le développement des tumeurs malignes syngéniques et son mécanisme. C. R. Acad. Sci. 276: 1911.Google Scholar
  12. Israël, L. (1973). Preliminary results of nonspecific immunotherapy for lung cancer. Cancer Chemother. Rep. 4: 283.Google Scholar
  13. Israël, L. and Halpern, B. (1972). Le Corynebacterium parvum dans les cancers avancés. Première évaluation de l’activité thérapeutique de cette immunostimuline. Nouv. Presse Med. 1: 19.PubMedGoogle Scholar
  14. Lamensans, A., Stiffel, C., Monier, M. F., Laurent, M., Mouton, D., and Biozzi, G. (1968). Effet protecteur de Corynebacterium parvum contre la leucémie greffée AKR. Relation avec l’activité catalasique hépatique et la fonction phagocytaire du système réticulo-endothélial. Rev. Fr. Etud. Clin. Biol. 23: 773.Google Scholar
  15. Leclerc, J. C., Gomard, E., and Lévy, J. P. (1972). Cell-mediated reaction against tumors induced by oncornaviruses. I. Kinetics and specificity of the immune response in murine sarcoma virus (MSV) induced tumors and transplanted lymphomas. Int. J. Cancer 10: 589.PubMedCrossRefGoogle Scholar
  16. Mathé, G. (1973). Attempt at using systemic immunity adjuvants in experimental and human cancer therapy. Immunopotentiation, p. 305 ( Ciba Foundation, New Series), Elsevier-Excerpta Medica, North-Holland, Amsterdam.Google Scholar
  17. Mathé, J. L., Pouillart, P., and Lapeyraque, F. (1969). Active immunotherapy of L1210 leukemia applied after the graft of tumor cells. Br. J. Cancer 23: 814.PubMedCrossRefGoogle Scholar
  18. Milas, L. and Mujagic, H. (1972). Protection by Corynebacterium parvum against tumor cells injected intravenously. Rev. Eur. Etud. Clin. Biol. 17: 498.PubMedGoogle Scholar
  19. Smith, L. H. and Woodruff, M. F. A. (1968). Comparative effect of two strains of Corynebacterium parvum on phagocytic activity and tumor growth. Nature (Loud.) 219: 197.CrossRefGoogle Scholar
  20. Woodruff, M. F. A. and Boak, J. L. (1966). Inhibitory effect of injection of Corynebacterium parvum on the growth of tumor transplants in isogenic hosts. Br. J. Cancer 20: 345.PubMedCrossRefGoogle Scholar
  21. Woodruff, M. F. A. and Dunbar, N. (1973). The effect of Corynebacterium parvum and other reticuloendothelial stimulants on transplanted tumors in mice. Immunopotentiation, p. 287 ( Ciba Foundation, New Series), Elsevier-Excerpta Medica, North-Holland, Amsterdam.Google Scholar

Copyright information

© Plenum Press, New York 1975

Authors and Affiliations

  • M. Roumiantzeff
    • 1
  • M. Musetescu
    • 1
  • G. Ayme
    • 1
  • M. C. Mynard
    • 1
  1. 1.Institut Français d’ImmunologieFondation Mérieux, Marcy l’EtoileCharbonnières-les-BainsFrance

Personalised recommendations